Ralph Winterhalder Selected Research

Ralph Winterhalder Research Topics

Disease

6	Neoplasms (Cancer) 02/2020 - 01/2012
6	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 11/2012
4	Breast Neoplasms (Breast Cancer) 10/2016 - 01/2011
3	Disease Progression 09/2014 - 11/2012
2	Hemorrhage 02/2020 - 01/2014
2	Lung Neoplasms (Lung Cancer) 01/2014 - 04/2006
1	Triple Negative Breast Neoplasms 01/2023
1	Adenocarcinoma 02/2020
1	Esophageal Neoplasms (Esophageal Cancer) 02/2020
1	Rectal Neoplasms (Rectal Cancer) 01/2017
1	Pneumonia (Pneumonitis) 12/2016
1	Thymoma (Thymic Carcinoma) 12/2016
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 12/2016
1	Fatigue 07/2015
1	Muscular Diseases (Myopathy) 07/2015
1	Nausea 07/2015
1	Vomiting 07/2015
1	Diabetes Mellitus 09/2014
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2014
1	Skin Neoplasms (Skin Cancer) 01/2014
1	Hypertension (High Blood Pressure) 01/2014
1	Melanoma (Melanoma, Malignant) 01/2014
1	Neoplasm Metastasis (Metastasis) 04/2013
1	Sarcoma (Soft Tissue Sarcoma) 04/2013
1	Lymphoma (Lymphomas) 04/2013
1	Hemangioblastoma 01/2012
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2004

Drug/Important Bio-Agent (IBA)

4	Docetaxel (Taxotere)FDA Link 02/2020 - 11/2012
3	Cetuximab (Erbitux)FDA Link 02/2020 - 11/2012
3	Prostate-Specific Antigen (Semenogelase)IBA 01/2019 - 11/2012
3	Capecitabine (Xeloda)FDA Link 01/2017 - 01/2011
2	Cisplatin (Platino)FDA LinkGeneric 02/2020 - 12/2004
2	Metformin (Glucophage)FDA LinkGeneric 01/2019 - 09/2014
2	Bevacizumab (Avastin)FDA Link 10/2016 - 01/2012
2	ErbB Receptors (EGF Receptor)IBA 11/2012 - 04/2006
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023
1	vinyltriethoxysilane (VTES)IBA 02/2020
1	abirateroneIBA 01/2019
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2017
1	enzalutamideIBA 01/2017
1	orteronelIBA 12/2016
1	pembrolizumabIBA 12/2016
1	AndrogensIBA 12/2016
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2016
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2016
1	Fulvestrant (Faslodex)FDA Link 07/2015
1	Aromatase InhibitorsIBA 07/2015
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 07/2015
1	AZD 6244IBA 07/2015
1	Cytidine Triphosphate (CTP)IBA 01/2014
1	Angiogenesis InhibitorsIBA 01/2014
1	Antihypertensive Agents (Antihypertensives)IBA 01/2014
1	Everolimus FDA Link 07/2013
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 07/2013
1	TensinsIBA 07/2013
1	Sirolimus (Rapamycin)FDA Link 07/2013
1	Biomarkers (Surrogate Marker)IBA 07/2013
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 07/2013
1	Edotreotide (SMT 487)IBA 04/2013
1	Somatostatin Receptors (Somatostatin Receptor)IBA 04/2013
1	Monoclonal AntibodiesIBA 11/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2012
1	Vinorelbine (Navelbine)FDA LinkGeneric 12/2004

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 02/2020 - 01/2011
7	Therapeutics 02/2020 - 04/2013
6	Castration 01/2019 - 11/2012
5	Radiotherapy 02/2020 - 12/2004
1	Neoadjuvant Therapy 02/2020
1	Aftercare (After-Treatment) 01/2012
1	Chemoprevention 04/2006